Share Name Share Symbol Market Type Share ISIN Share Description
AstraZeneca LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +29.00p +0.57% 5,152.00p 5,154.00p 5,156.00p 5,172.00p 5,120.00p 5,135.00p 1,932,147 16:35:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 18,627.4 2,876.5 224.3 24.2 65,205.81

AstraZeneca (AZN) Latest News (1)

More AstraZeneca News
AstraZeneca Takeover Rumours

AstraZeneca (AZN) Share Charts

1 Year AstraZeneca Chart

1 Year AstraZeneca Chart

1 Month AstraZeneca Chart

1 Month AstraZeneca Chart

Intraday AstraZeneca Chart

Intraday AstraZeneca Chart

AstraZeneca (AZN) Discussions and Chat

AstraZeneca Forums and Chat

Date Time Title Posts
03/4/201720:08Potential Reaction on AstraZeneca (AZN)-
29/8/201618:09Analysts' View on AstraZeneca (AZN)-
29/8/201600:47*** AstraZeneca *** 357
14/3/201613:28AstraZeneca : 38.1% Potential Upside Indicated by Deutsche Bank4

Add a New Thread

AstraZeneca (AZN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all AstraZeneca trades in real-time

AstraZeneca (AZN) Top Chat Posts

AstraZeneca Daily Update: AstraZeneca is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker AZN. The last closing price for AstraZeneca was 5,123p.
AstraZeneca has a 4 week average price of 4,875p and a 12 week average price of 4,596p.
The 1 year high share price is 5,520p while the 1 year low share price is currently 3,996p.
There are currently 1,265,640,640 shares in issue and the average daily traded volume is 2,367,727 shares. The market capitalisation of AstraZeneca is £65,205,805,772.80.
steeplejack: Goldmans issued a sell note on the 24 Jan with a £39 share price target.Thats probably still washing through.
philanderer: "Is Neil Woodford a fool to continue pumping money into Capita plc and AstraZeneca plc? 'Patience' AstraZeneca is Woodford's largest holding and an example of just how long he's prepared to be patient with a company he views as intrinsically undervalued. Earnings at the pharma group have suffered as a result of expiring patents on some of its top sellers and no improvement is expected to the bottom line until 2018. However, the company has maintained its dividend through this difficult period and offers a 5% yield at a current share price of around 4,400p. The dividend is forecast to start rising with the resumption of earnings growth in 2018 as a result of Astra's reinvigorated drugs pipeline. HTTP://
bili1946: I have looked through the last months target share price from 12 brokers.....range from £46 to £60? Today,s latest £55?
nisbet: Monty, you really don't understand what is happening. AstraZeneca has seen a boost to its earnings in sterling equivalent to the diminution of sterling's value relative to the U.S. dollar. Consequently, a relative re-rating is taking place. In addition, (an added bonus) the Astra dividend is paid in U.S. Dollars so its yield is buttressed to a level which provokes a relative adjustment. This happens by way of a rising share price. In summation, your observations and views can best be described as naive and lacking in erudition.
kevdav0: Oh help what is happening to our share price. Something is causing this
philanderer: ‘Hold’ AstraZeneca for ‘cutting-edge’ drugs pipeline Shore Capital has resumed coverage of pharmaceutical giant AstraZeneca (AZN) as the company undergoes a period of transition. Shore Capital analyst Tara Raveendran initiated coverage of the UK drugs company with a ‘hold’ but did not set a share price target. ‘AstraZeneca is undergoing a period of transition,’ she said. ‘Its mature franchises are slowing in the face of competition and genericisation, however, it boasts a full but emerging pipeline of unique assets in existing and new therapeutic areas that are not yet contributing to the top-line. ‘While we are more positive over the medium to longer term, encouraged by management’s commitment to cutting-edge science and its exciting pipeline, lacklustre earnings and limited pipeline visibility are likely to be near-term overhangs for the stock,’ she added. This week the company borrowed €2.2 billion in a private loan note placing on which it will pay a fixed coupons of 0.25%, 0.75% and 1.25%. Yesterday the shares added 8.5p or 0.2% to £39.36. HTTP://
kdconn: What a bad day . Looks like share price will hit £37 or worse still below . Is there any way back .
kevdav0: Why has the market reacted so badly to TAKEDA RESPIRATORY takeover. Share price is heading towards £37 which is just awful.
indianspan: AstraZeneca plc with EPIC/TICKER had its stock rating noted as Retains with the recommendation being set at BUY this morning by analysts at Deutsche Bank. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Deutsche Bank have set a target price of 5700 GBX on its stock. This now indicates the analyst believes there is a possible upside of 38.1% from the opening price of 4128.5 GBX. Over the last 30 and 90 trading days the company share price has decreased 82 points and decreased 171.5 points respectively. AstraZeneca plc has a 50 day moving average of 4,407.83 GBX and a 200 day moving average of 4,329.91 GBX. The 52 week high share price is 4931.68 GBX while the 52 week low is 3746 GBX. There are currently 1,261,546,027 shares in issue with the average daily volume traded being 3,095,152. Market capitalisation for is 51,994,619,5ase (CKD), diabetes mellitus (DM) and chronic heart failure (CHF). All rights reserved (c) 2016 The Jerusalem Post Provided by SyndiGate Media Inc. (, source Middle East & North African Newspapers Envoyer par mail 03 GBP.
harvester: Share price below indicative offer since not all cash offer and risk of pfizer share price weakening as well as risk of the deal failing . AZN share price closed last night at 4851 up 151 based on suspicious after hours trades . At normal market close the share price was 4676.5 . Big money at stake. Hence bound to be some insider trading going on .
AstraZeneca share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170721 20:43:57